About us

Our Mission

We exist to utilize our multi-target cell and gene therapy platform to develop curative therapies for chronic wound, cancer, and inflammatory disease patients.

Our Vision

Our goal is to create solid clinical safety and efficacy data in Diabetic Foot Ulcer, other chronic wounds and deadly cancers, and to engage with strategic partners to enable market entry to ensure that this game-changing technology platform benefits millions of patients throughout the world.

SCIENTIFIC ADVISORY BOARD

BOARD OF DIRECTORS

Serial Entrepreneur, Board Professional and Biotech Business Advisor

Biotech Investor, Senior Executive and Board Professional

TEAM MEMBERS

Director of Genetic Engineering & Manufacturing

Head of Pre-Clinical & Pharmacology

Head of Quality & Regulatory Affairs

Senior Clinical Project Manager

Project Manager CMC

Marketing & Communications Manager

Picture of Pia Nevalainen

PIA NEVALAINEN

Senior Executive Assistant

Do you have any questions to our team? Get in touch.

Contact us